Hozefa A. Divan

878 total citations
24 papers, 582 citations indexed

About

Hozefa A. Divan is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Hozefa A. Divan has authored 24 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Hozefa A. Divan's work include Hormonal and reproductive studies (4 papers), Child Development and Digital Technology (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Hozefa A. Divan is often cited by papers focused on Hormonal and reproductive studies (4 papers), Child Development and Digital Technology (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Hozefa A. Divan collaborates with scholars based in United States, Denmark and Canada. Hozefa A. Divan's co-authors include Jørn Olsen, Leeka Kheifets, Carsten Obel, J. Curtis Nickel, Susan S. Jick, Katrina Wilcox Hagberg, Amanda J. Cross, Fred F. Kadlubar, Martin Kulldorff and Mary H. Ward and has published in prestigious journals such as Journal of Clinical Oncology, Kidney International and BMJ.

In The Last Decade

Hozefa A. Divan

24 papers receiving 546 citations

Peers

Hozefa A. Divan
Fnu Deepinder United States
S.A. Oliveria United States
Wen Jin China
Emma Fernández–Repollet Puerto Rico
Hamidah Alias Malaysia
Jaqueline Schölz Issa Brazil
V. Lauwers‐Cancès France
Ellen Provost United States
William P. Walsh United States
Simon Reif South Africa
Fnu Deepinder United States
Hozefa A. Divan
Citations per year, relative to Hozefa A. Divan Hozefa A. Divan (= 1×) peers Fnu Deepinder

Countries citing papers authored by Hozefa A. Divan

Since Specialization
Citations

This map shows the geographic impact of Hozefa A. Divan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hozefa A. Divan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hozefa A. Divan more than expected).

Fields of papers citing papers by Hozefa A. Divan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hozefa A. Divan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hozefa A. Divan. The network helps show where Hozefa A. Divan may publish in the future.

Co-authorship network of co-authors of Hozefa A. Divan

This figure shows the co-authorship network connecting the top 25 collaborators of Hozefa A. Divan. A scholar is included among the top collaborators of Hozefa A. Divan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hozefa A. Divan. Hozefa A. Divan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Divan, Hozefa A., et al.. (2024). Real-world patient characteristics and treatment patterns in US patients with advanced non-small cell lung cancer. BMC Cancer. 24(1). 424–424. 3 indexed citations
2.
3.
4.
Lin, Peggy L., Dominick Latrémouille-Viau, Medha Sasané, et al.. (2019). Treatment patterns in patients with multiple myeloma (MM): A retrospective study using Medicare data.. Journal of Clinical Oncology. 37(15_suppl). e19506–e19506. 1 indexed citations
5.
Hagberg, Katrina Wilcox, Hozefa A. Divan, Shona Fang, J. Curtis Nickel, & Susan S. Jick. (2017). Risk of gynecomastia and breast cancer associated with the use of 5-alpha reductase inhibitors for benign prostatic hyperplasia. Clinical Epidemiology. Volume 9. 83–91. 18 indexed citations
6.
Patel, Minal, Ritesh Mistry, Annette E. Maxwell, Hozefa A. Divan, & William J. McCarthy. (2017). Contextual Factors Related to Conventional and Traditional Tobacco Use Among California Asian Indian Immigrants. Journal of Community Health. 43(2). 280–290. 7 indexed citations
7.
Hagberg, Katrina Wilcox, Hozefa A. Divan, J. Curtis Nickel, & Susan S. Jick. (2017). Risk of Incident Antidepressant‐Treated Depression Associated with Use of 5α‐Reductase Inhibitors Compared with Use of α‐Blockers in Men with Benign Prostatic Hyperplasia: A Population‐Based Study Using the Clinical Practice Research Datalink. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 37(5). 517–527. 11 indexed citations
8.
Hagberg, Katrina Wilcox, Hozefa A. Divan, Rebecca Persson, et al.. (2017). Impact of 5-alpha reductase inhibitors for treatment of benign prostatic hyperplasia on erectile dysfunction, treated depression, gynecomastia, and breast cancer: A real world 20 year observational study. European Urology Supplements. 16(3). e919–e919. 1 indexed citations
9.
Debruyne, F.M.J., Hermann M. Behre, Claus G. Roehrborn, et al.. (2016). Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men. British Journal of Urology. 119(2). 216–224. 59 indexed citations
10.
Hagberg, Katrina Wilcox, Hozefa A. Divan, Rebecca Persson, J. Curtis Nickel, & Susan S. Jick. (2016). Risk of erectile dysfunction associated with use of 5-α reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink. BMJ. 354. i4823–i4823. 23 indexed citations
11.
Sudan, Madhuri, Leeka Kheifets, Onyebuchi A. Arah, Hozefa A. Divan, & Jørn Olsen. (2013). Complexities of sibling analysis when exposures and outcomes change with time and birth order. Journal of Exposure Science & Environmental Epidemiology. 24(5). 482–488. 10 indexed citations
12.
Bharmal, Nazleen, Robert M. Kaplan, Martin F. Shapiro, et al.. (2013). The association of religiosity with overweight/obese body mass index among Asian Indian immigrants in California. Preventive Medicine. 57(4). 315–321. 22 indexed citations
13.
Menis, Mikhail, Gayathri Sridhar, Nandini Selvam, et al.. (2013). Hyperimmune globulins and same‐day thrombotic adverse events as recorded in a large healthcare database during 2008–2011. American Journal of Hematology. 88(12). 1035–1040. 36 indexed citations
14.
Divan, Hozefa A., Leeka Kheifets, & Jørn Olsen. (2011). Prenatal cell phone use and developmental milestone delays among infants. Scandinavian Journal of Work Environment & Health. 37(4). 341–348. 23 indexed citations
15.
Divan, Hozefa A., Leeka Kheifets, Carsten Obel, & Jørn Olsen. (2010). Cell phone use and behavioural problems in young children. Journal of Epidemiology & Community Health. 66(6). 524–529. 86 indexed citations
16.
Divan, Hozefa A., Leeka Kheifets, Carsten Obel, & Jørn Olsen. (2008). Prenatal and Postnatal Exposure to Cell Phone Use and Behavioral Problems in Children. Epidemiology. 19(4). 523–529. 132 indexed citations
17.
Ward, Mary H., Amanda J. Cross, Hozefa A. Divan, et al.. (2007). Processed meat intake, CYP2A6 activity and risk of colorectal adenoma. Carcinogenesis. 28(6). 1210–1216. 49 indexed citations
18.
Divan, Hozefa A.. (2005). Cancer incidence and mortality in Asian Indians: a review of literature from the United States, South Asia, and beyond.. PubMed. 10(2). 73–85. 5 indexed citations
19.
Rahman, Mohammad Hifz Ur, et al.. (2005). Prevalence and predictors of smoking behavior among Vietnamese men living in California. Nicotine & Tobacco Research. 7(1). 103–109. 25 indexed citations
20.
Tomashek, Kay M., Leslie Spry, Diane M. Dwyer, et al.. (2000). Multistate outbreak of hemolysis in hemodialysis patients traced to faulty blood tubing sets. Kidney International. 57(4). 1668–1674. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fnu Deepinder Breakdown of academic impact, for papers by S.A. Oliveria Breakdown of academic impact, for papers by Wen Jin Breakdown of academic impact, for papers by Emma Fernández–Repollet Breakdown of academic impact, for papers by Hamidah Alias Breakdown of academic impact, for papers by Jaqueline Schölz Issa Breakdown of academic impact, for papers by V. Lauwers‐Cancès Breakdown of academic impact, for papers by Ellen Provost Breakdown of academic impact, for papers by William P. Walsh Breakdown of academic impact, for papers by Simon Reif
Rankless by CCL
2026